首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺表面活性物质防治早产儿肺透明膜病的临床回顾性分析
引用本文:方平,陈玉蓉,黄丽秀.肺表面活性物质防治早产儿肺透明膜病的临床回顾性分析[J].川北医学院学报,2010,25(6):519-521.
作者姓名:方平  陈玉蓉  黄丽秀
作者单位:川北医学院附属医院儿科,四川,南充,637000;川北医学院附属医院儿科,四川,南充,637000;川北医学院附属医院儿科,四川,南充,637000
摘    要:目的:探讨肺表面活性物质(PS)防治早产儿肺透明膜病(HMD)的临床疗效。方法:155例出生体重<1500g或胎龄<34周的早产儿根据应用PS与否分为PS组(72例)和对照组(83例),比较两组早产儿HMD发病、并发症发生及转归情况、呼吸机使用、吸氧时间、体重增长及住院时间有无差异。结果:PS组的HMD及并发症发生率均低于对照组,呼吸机使用、吸氧时间及住院时间短于对照组,而体重增长优于对照组。结论:应用PS可降低早产儿HMD发生并改善早产儿预后。

关 键 词:肺表面活性物质  早产儿  肺透明膜病

Retrospective Analysis of Pulmonary Surfactant in the Prevention and Treatment of Hyaline Membrane Disease in Premature Infants
FANG Ping,CHEN Yu-rong,HUANG Li-xiu.Retrospective Analysis of Pulmonary Surfactant in the Prevention and Treatment of Hyaline Membrane Disease in Premature Infants[J].Journal of North Sichuan Medical College,2010,25(6):519-521.
Authors:FANG Ping  CHEN Yu-rong  HUANG Li-xiu
Institution:FANG Ping,CHEN Yu-rong,HUANG Li-xiu(The Affiliated Hospital of North Sichuan Medical College,Nanchong,Sichuan 637000)
Abstract:Objective: To evaluate the clinical efficacy of pulmonary surfactant(PS) in the prevention and treatment of hyaline membrane disease in premature infants.Methods: 155 premature infants with birth weight less than 1500g or gestational age less than 34 weeks were divided into a PS group(72 cases) and a control group(83 cases).The incidence of hyaline membrane disease(HMD),complications,prognosis,the time of the application of ventilator and usage of oxygen,the period in hospital stay and the weight gain were ...
Keywords:Pulmonary surfactant  Premature infants  Hyaline membrane disease  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号